INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 130 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2015. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,293 | +601.2% | 42,348 | +584.2% | 0.00% | – |
| Q4 2022 | $327 | -99.9% | 6,189 | -45.9% | 0.00% | -100.0% |
| Q3 2022 | $531,000 | +172.3% | 11,431 | +98.5% | 0.00% | – |
| Q1 2021 | $195,000 | -77.1% | 5,758 | -78.5% | 0.00% | -100.0% |
| Q4 2020 | $853,000 | +10.1% | 26,839 | -11.1% | 0.00% | 0.0% |
| Q3 2020 | $775,000 | -37.9% | 30,207 | -37.9% | 0.00% | -50.0% |
| Q2 2020 | $1,248,000 | +109.4% | 48,634 | +25.3% | 0.00% | +100.0% |
| Q1 2020 | $596,000 | -53.7% | 38,825 | +3.4% | 0.00% | -66.7% |
| Q4 2019 | $1,288,000 | +186.9% | 37,557 | -37.6% | 0.00% | +200.0% |
| Q3 2019 | $449,000 | -36.8% | 60,211 | +84.0% | 0.00% | -50.0% |
| Q3 2018 | $710,000 | +57.1% | 32,722 | +27.9% | 0.00% | 0.0% |
| Q2 2018 | $452,000 | -32.5% | 25,587 | -19.6% | 0.00% | -93.1% |
| Q1 2018 | $670,000 | +43.2% | 31,842 | -1.6% | 0.03% | +45.0% |
| Q4 2017 | $468,000 | -19.4% | 32,367 | -12.2% | 0.02% | -16.7% |
| Q3 2017 | $581,000 | +50.1% | 36,852 | +18.1% | 0.02% | +41.2% |
| Q2 2017 | $387,000 | +19250.0% | 31,214 | +20168.8% | 0.02% | – |
| Q1 2017 | $2,000 | -99.3% | 154 | -99.2% | 0.00% | -100.0% |
| Q4 2016 | $278,000 | -82.4% | 18,475 | -82.1% | 0.02% | -84.1% |
| Q3 2016 | $1,576,000 | +2990.2% | 103,463 | +5441.7% | 0.11% | +2575.0% |
| Q1 2016 | $51,000 | -79.2% | 1,867 | -69.6% | 0.00% | -77.8% |
| Q3 2015 | $245,000 | – | 6,143 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |